Literature DB >> 2727900

Intraoperative radiation therapy for biliary tract carcinoma: results of a 5-year experience.

P M Busse1, M D Stone, T A Sheldon, J T Chaffey, B Cady, W V McDermott, A Bothe, R Jenkins, G Steele.   

Abstract

The results of a 5-year experience with use of intraoperative radiation therapy (IORT) in the management of locally advanced bile duct carcinoma are presented. Fifteen patients received IORT doses between 5 and 20 Gy for localized disease, which was either primary and resected with microscopic residual (2 patients), primary and unresected (10 patients), or recurrent (3 patients). Thirteen patients also received postoperative radiation therapy. The median survival of the 12 patients with primary disease was 14 months, with disease controlled in the porta hepatis in 5 of 10 evaluable patients. The three patients with recurrent disease survived 2, 9, and 11 months. There were two operative deaths, for an operative mortality of 13%. Acute and chronic complications are reviewed. Cholangitis is the most frequent in both categories. This aggressive approach in the therapy for advanced disease has an acceptable level of morbidity and may warrant the use of IORT as part of the management of biliary tract cancer.

Entities:  

Mesh:

Year:  1989        PMID: 2727900

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

1.  A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma.

Authors:  T E Bowling; S M Galbraith; A R Hatfield; J Solano; M F Spittle
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

Review 2.  External beam plus intraoperative irradiation for gastrointestinal cancers.

Authors:  L L Gunderson; D M Nagorney; J A Martenson; J H Donohue; G R Garton; H Nelson; J Fieck
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 3.  Surgical treatment in proximal bile duct cancer. A single-center experience.

Authors:  R Pichlmayr; A Weimann; J Klempnauer; K J Oldhafer; H Maschek; G Tusch; B Ringe
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

4.  Intraoperative radiation therapy for carcinoma of the gallbladder.

Authors:  P M Busse; B Cady; A Bothe; R Jenkins; W V McDermott; G Steele; M D Stone
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

5.  Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival.

Authors:  H A Pitt; A Nakeeb; R A Abrams; J Coleman; S Piantadosi; C J Yeo; K D Lillemore; J L Cameron
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

6.  Combined cytosine deaminase expression, 5-fluorocytosine exposure, and radiotherapy increases cytotoxicity to cholangiocarcinoma cells.

Authors:  L C Pederson; S M Vickers; D J Buchsbaum; S R Kancharla; M S Mayo; D T Curiel; M A Stackhouse
Journal:  J Gastrointest Surg       Date:  1998 May-Jun       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.